AL8326
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for AL8326, covering 2021-05-18 to 2026-02-06. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I/IIa Study of AL8326 Combined With Toripalimab in the Treatment of Advanced Solid Tumors. [Phase 1, Phase 2]